Chemical Market Reports

Global Traveler?s Diarrhea Therapeutics Market By Type (Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, and Other), By Application (Adult Traveler's Diarrhea, and Children Traveler's Diarrhea), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 139928
  • 19-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Traveler s Diarrhea Therapeutics Market is estimated to be valued US$ XX.X million in 2019. The report on Traveler s Diarrhea Therapeutics Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global traveler s diarrhea therapeutics market is segmented on the basis of Type, Application, and geography.

    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    Traveler s Diarrhea Therapeutics Market Scope:

    By type, the market is segmented into Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, and Other. By Application, the market is divided into Adult Traveler’s Diarrhea, and Children Traveler’s Diarrhea.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, and Immuron.

    Key Market Segments

    Type

    Immunization
    Non-antibiotic Agents
    Antibiotics
    Anti-Motility Agents
    Other

    Application

    Adult Traveler’s Diarrhea
    Children Traveler’s Diarrhea

    Key Market Players included in the report:

    Salix Pharmaceuticals
    P&G
    Johnson & Johnson
    Otsuka Pharma
    Valneva
    Shanghai United Cell
    PaxVax
    Livzon
    Immuron

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Traveler s Diarrhea Therapeutics Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Traveler s Diarrhea Therapeutics Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Traveler s Diarrhea Therapeutics Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Traveler s Diarrhea Therapeutics Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Traveler s Diarrhea Therapeutics Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Traveler s Diarrhea Therapeutics Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Traveler s Diarrhea Therapeutics sub-markets, depending on key regions (various vital states).
    To analyze Traveler s Diarrhea Therapeutics Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Traveler s Diarrhea Therapeutics Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Traveler s Diarrhea Therapeutics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content

    1. Traveler?s Diarrhea Therapeutics Market Introduction

    1.1. Definition
    1.2. Taxonomy
    1.3. Research Scope

    2. Executive Summary

    2.1. Key Findings by Major Segments
    2.2. Top strategies by Major Players

    3. Global Traveler?s Diarrhea Therapeutics Market Overview

    3.1. Traveler?s Diarrhea Therapeutics Market Dynamics

    3.1.1. Drivers
    3.1.2. Opportunities
    3.1.3. Restraints
    3.1.4. Challenges

    3.2. PESTLE Analysis
    3.3. Opportunity Map Analysis
    3.4. PORTER’S Five Forces Analysis
    3.5. Market Competition Scenario Analysis
    3.6. Product Life Cycle Analysis
    3.7. Opportunity Orbits
    3.8. Production Analysis by Region/Company
    3.9. Industry chain Analysis
    3.10. Marketing Strategy

    4. Global Traveler?s Diarrhea Therapeutics Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028

    4.1. Global Traveler?s Diarrhea Therapeutics Market Analysis by Type: Introduction
    4.2. Market Size and Forecast by Region
    4.3. Immunization

    4.4. Non-antibiotic Agents

    4.5. Antibiotics

    4.6. Anti-Motility Agents

    4.7. Other

    5. Global Traveler?s Diarrhea Therapeutics Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028

    5.1. Global Traveler?s Diarrhea Therapeutics Market Analysis by Application: Introduction
    5.2. Market Size and Forecast by Region
    5.3. Adult Traveler’s Diarrhea

    5.4. Children Traveler’s Diarrhea

    6. Global Traveler?s Diarrhea Therapeutics Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028

    6.1. North America

    6.1.1. North America Traveler?s Diarrhea Therapeutics Market: Regional Trend Analysis

    6.1.1.1. US
    6.1.1.2. Canada
    6.1.1.3. Mexico

    6.2.1. Europe

    6.2.1. Europe Traveler?s Diarrhea Therapeutics Market: Regional Trend Analysis

    6.2.1.1. Germany
    6.2.1.2. France
    6.2.1.3. UK
    6.2.1.4. Russia
    6.2.1.5. Italy
    6.2.1.6. Spain
    6.2.1.7. Rest of Europe

    6.3. Asia-Pacific

    6.3.1. Asia-Pacific Traveler?s Diarrhea Therapeutics Market: Regional Trend Analysis

    6.3.1.1. China
    6.3.1.2. Japan
    6.3.1.3. Korea
    6.3.1.4. India
    6.3.1.5. Rest of Asia-Pacific

    6.4. Latin America

    6.4.1. Latin America Traveler?s Diarrhea Therapeutics Market: Regional Trend Analysis

    6.4.1.1. Brazil
    6.4.1.2. Argentina
    6.4.1.3. Rest of Latin America

    6.5. Middle East and Africa

    6.5.1. Middle East and Africa Traveler?s Diarrhea Therapeutics Market: Regional Trend Analysis

    6.5.1.1. GCC
    6.5.1.2. South Africa
    6.5.1.3. Israel
    6.5.1.4. Rest of MEA

    7. Global Traveler?s Diarrhea Therapeutics Market Competitive Landscape, Market Share Analysis, and Company Profiles

    7.1. Market Share Analysis
    7.2. Company Profiles
    7.3. Salix Pharmaceuticals

    7.3.1. Company Overview
    7.3.2. Financial Highlights
    7.3.3. Product Portfolio
    7.3.4. SWOT Analysis
    7.3.5. Key Strategies and Developments

    7.4. P&G

    7.4.1. Company Overview
    7.4.2. Financial Highlights
    7.4.3. Product Portfolio
    7.4.4. SWOT Analysis
    7.4.5. Key Strategies and Developments

    7.5. Johnson & Johnson

    7.5.1. Company Overview
    7.5.2. Financial Highlights
    7.5.3. Product Portfolio
    7.5.4. SWOT Analysis
    7.5.5. Key Strategies and Developments

    7.6. Otsuka Pharma

    7.6.1. Company Overview
    7.6.2. Financial Highlights
    7.6.3. Product Portfolio
    7.6.4. SWOT Analysis
    7.6.5. Key Strategies and Developments

    7.7. Valneva

    7.7.1. Company Overview
    7.7.2. Financial Highlights
    7.7.3. Product Portfolio
    7.7.4. SWOT Analysis
    7.7.5. Key Strategies and Developments

    7.8. Shanghai (US$ Mn & ‘000 Units)ed Cell

    7.8.1. Company Overview
    7.8.2. Financial Highlights
    7.8.3. Product Portfolio
    7.8.4. SWOT Analysis
    7.8.5. Key Strategies and Developments

    7.9. PaxVax

    7.9.1. Company Overview
    7.9.2. Financial Highlights
    7.9.3. Product Portfolio
    7.9.4. SWOT Analysis
    7.9.5. Key Strategies and Developments

    7.10. Livzon

    7.10.1. Company Overview
    7.10.2. Financial Highlights
    7.10.3. Product Portfolio
    7.10.4. SWOT Analysis
    7.10.5. Key Strategies and Developments

    7.11. Immuron

    7.11.1. Company Overview
    7.11.2. Financial Highlights
    7.11.3. Product Portfolio
    7.11.4. SWOT Analysis
    7.11.5. Key Strategies and Developments

    8. Assumptions and Acronyms
    9. Research Methodology
    10. Contact

  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. Office No 8, 3rd Floor, Aston Plaza, Katraj - Ambegaon Road, Ambegaon BK, Pune, Maharashtra, India. Pin- 411046